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In this issue of Haemophilia, the manuscript from Yaoi et al. describes 
the use of a new microfluidic platform (t- TAS) to examine bleeding 
associated with severe anaemia.1 The new tool has advantages over 
most traditional compartmental and global coagulation assays in that 
it evaluates platelet thrombus formation under conditions of flow 
and shear stress. In doing so, they demonstrate the importance of 
red blood cells (RBCs) in haemostasis. Specifically, they posit that 
RBCs act to physically marginate platelets to the vessel wall and en-
able platelet activation and thrombus formation under high shear 
conditions. We have often noted prolonged PFA- 100 (a test that 
also involves flow and very high shear) times in anaemic patients 
but long considered this an artefact or limitation of the test. In this 
study, the authors used t- TAS to measure thrombus formation under 
high and very high shear conditions and demonstrate that this tool 
correlated with the clinical findings in a young woman with type I 
mild von Willebrand disease with menorrhagia. The patient contin-
ued to bleed and have an abnormal t- TAS in spite of full correction 
of von Willebrand factor (VWF) levels but stopped bleeding after 
packed RBC transfusion. They went on to demonstrate using ex 
vivo- manipulated samples that t- TAS was sensitive to both VWF lev-
els and haematocrit.
As we enter the postgenomic era, laboratory tools to monitor 
bleeding phenotype have only become more important. Genetics 
and molecular biology have given us great insight into bleeding phe-
nomena but approaching unanswered questions will require detailed 
mechanistic understanding of coagulation and better phenotyping. 
Better phenotyping will rely on new tools such as t- TAS that allow us 
to examine the role of heretofore unevaluated but important factors in 
haemostasis including dynamic measures under physiologic conditions 
and the role of endothelium.
I recently came across a book, entitled The Sports Gene,2 that re-
ports on the role of genetics in athletic performance. In the first chap-
ter, the author relays a story about major league baseball’s best hitters 
and Jennifer Finch, the star pitcher for the USA Olympic Softball team. 
Albert Pujols, Barry Bonds and other all stars were unable to hit her 
pitches. It turns out that the assumption that outstanding hitters rely 
on coordination and trigger fast reflexes was wrong. Outstanding hit-
ters recognize patterns of arm movement and baseball rotation very 
quickly upon release of a pitch and superior recognition guides their 
hitting. Further studies identified that superior visual acuity, percep-
tion and ability to track moving objects are more important to hitting 
than reaction time or bat speed. An examination of the Los Angeles 
Dodgers team revealed that more than half of the Dodgers position 
players had visual acuity of 20/10 or better (which fewer than 1% of 
the general population have). If we were to look for genetic or mech-
anistic biology underlying good hitting based on reaction times or bat 
speed, we would be unlikely to find it. Only by identifying that supe-
rior visual acuity defines the phenotype of good hitting could we get 
to the biology. Similarly, if we define laboratory phenotypes based on 
components of haemostasis without flow condition, we would miss 
the important role of RBCs.
The complex interplay between genes, non- coding DNA, epi-
genetics and environment constitute so many variables that systemat-
ically evaluating them from an unbiased perspective exceeds capacity 
of subjects in the world and they must be evaluated in relation to phe-
notypes which are often inaccurate, incomplete or mischaracterized. In 
Dickens’ A Christmas Carol, Ebeneezer Scrooge is visited by the ghosts 
of Christmas—past, present and future. Modern science is now visited 
by the legends of haematology—past, present and future. The legends 
of haematology past used thorough clinical evaluation to identify spe-
cific phenotypes and separate them into disorders that allow us to test 
interventions and improve care. The legends of haematology present 
have used powerful genetic and molecular biology tools to identify 
the underlying defects behind these phenotypes and target these de-
fects to improve care. After the completely penetrant monogenic and 
deterministic environmental causes of disease have been determined 
through state of the art genetic and molecular biology evaluation, 
there will remain many important unanswered questions. The legends 
of haematology future will need to incorporate mechanistic gene and 
protein level understanding of biology into complex physiologically 
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driven models, combining this with new tools and understanding of 
complex phenotypes to improve our understanding of haematologic 
diseases and improve care for our patients moving forward. Yaoi et al. 
have re- examined the laboratory phenotype in bleeding patients using 
an important new tool that incorporates flow and shear enabling us to 
identify factors and further characterize bleeding phenotypes previ-
ously unrecognized in the clinical laboratory.
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